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Correlation of renal histopathology with sonographic findings.
Background. Judgments about irreversible renal disease are
frequently based on the sonographic appearance of the kidneys.
However, the sensitivity and specificity of sonography in identi-
fying chronic, irreversible disease have never been determined,
and the specific pathologic changes that increase renal cortical
echogenicity have not been defined.
Methods. We retrospectively compared sonographic param-
eters (length, quantitative echogenicity, cortical thickness, and
parenchymal thickness) to biopsy findings of glomerular sclero-
sis, tubular atrophy, interstitial fibrosis, and interstitial inflam-
mation in 207 patients.
Results. Echogenicity showed the strongest correlation with
all 4 histologic parameters (r = 0.28–0.35). Renal size was sig-
nificantly correlated with glomerular sclerosis (r = −0.26) and
tubular atrophy (r = 0.20). Parenchymal thickness, but not cor-
tical thickness, correlated with tubular atrophy (r = −0.23). By
multivariate analysis, tubular atrophy and interstitial inflamma-
tion, but not interstitial fibrosis, were significant determinants of
cortical echogenicity. Severe chronic disease (>50% sclerosed
glomeruli or a score of 3 out of 5 or greater for tubular atrophy
or interstitial fibrosis) was present in 69% and 47% of patients
with combined renal length <20 cm and >20 cm, respectively
(P = <0.05). For cortical echogenicity >1.0 (>liver echogenic-
ity) and ≤1.0, the proportions of severe disease were 66% and
30%, respectively (P < 0.001). Severe disease was present in
86% of patients with combined renal length <20 cm and corti-
cal echogenicity >1.0.
Conclusion. Cortical echogenicity is the sonographic parame-
ter that correlates best with renal histopathology. Although size
or echogenicity alone are poor predictors of chronic irreversible
disease, the likelihood of treatable disease in small kidneys with
increased cortical echogenicity is very low.
Sonography of the kidneys is frequently employed dur-
ing the evaluation of renal failure. In addition to visu-
alizing a dilated collecting system, sonography provides
information on renal size and the thickness and
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echogenicity of the renal cortex. These parameters are
thought to provide an indication of the presence or ab-
sence of irreversible parenchymal damage [1–4], and of-
ten figure into decisions about whether to perform a renal
biopsy, but clinically useful thresholds have never been
established. Thinning of the renal cortex and reduced re-
nal size are likely the result of tubular atrophy. Unfortu-
nately, there are very limited normative data on which to
judge cortical thinning and, although such data do exist
for kidney size, the extent to which a reduction in size
correlates with parenchymal disease is unknown. Even
less information is available on echogenicity of the renal
cortex, which is the backscatter of sound that, in normal
cortex, is produced by structures such as glomeruli, ves-
sels, and tubules [5]. It is assumed that collagen present in
interstitial fibrosis and glomerulosclerosis is responsible
for increased echogenicity [4], but this has never been
established. Interstitial inflammation may also increase
echogenicity [1]. Furthermore, echogenicity is usually as-
sessed qualitatively by the human eye, which is very unre-
liable [6, 7], and there is no established normal range. We
recently showed that echogenicity of the renal cortex can
be reliably quantitated, and established a normal range
in a small group of adults [8].
In a previous study comparing sonographic and patho-
logic findings [4], significant correlations were found
between length or cortical echogenicity and glomerular
sclerosis or tubular atrophy. Surprisingly, there was no
correlation between echogenicity and interstitial fibrosis.
However, echogenicity was assessed qualitatively, and no
clinically useful thresholds for sonographic parameters
were presented. Furthermore, there have been consider-
able advances in sonographic imaging since this report.
Because the extent to which sonographic parameters can
predict parenchymal disease has never been established,
we correlated histologic findings with sonographic pa-
rameters in a large number of patients in whom both
sonography and renal biopsy were performed. We sought
to validate the correlation between sonographic parame-
ters and parenchymal disease, and to establish thresholds
for size and echogenicity that could be useful in making
clinical decisions.
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Fig. 1. Sonographic measurements. Diagram
of a normal kidney in coronal section (A)
and longitudinal sonogram of left kidney (B)
showing the different measurements used.
Parallel lines indicate cortical thickness, solid
arrows indicate parenchymal thickness, and
dashed arrows or dotted line indicate maxi-
mal kidney length.
METHODS
Patients
Patients were identified from a database of all sono-
graphic studies performed by the Renal Division since
August 1996. Only patients who underwent ultrasound-
guided percutaneous renal biopsy of a native kidney, and
who had undergone diagnostic sonography of their kid-
neys between 6 months before and 3 weeks after the
biopsy, were included in this study. Of the 419 biopsies
performed between August 1996 and September 2002,
207 met the inclusion criteria.
Sonography
All sonograms were performed with an RT3200 scan-
ner (GE Medical Systems, Milwaukee, WI, USA) using
a 5.0 MHz wide-frequency band, phased array probe, or
with an SDU 450 scanner (Shimadzu, Mountain View,
CA, USA) using a 3.0 to 5.0 MHz variable frequency,
phased array probe. Output was onto thermal printer pa-
per. All studies were performed by nephrology trainees
or faculty thoroughly trained in the procedure, and were
interpreted by 1 of 2 experienced nephrologists. Kidney
length was determined as the maximum longitudinal di-
mension, measured at the time of the sonogram, while
quantitative determinations of parenchymal thickness,
cortical thickness, and echogenicity were performed at
a later date for the purpose of this study. The investi-
gators performing these measurements were unaware of
the pathologic findings. Parenchymal thickness was deter-
mined as the shortest distance from the renal sinus fat to
the renal capsule, and cortical thickness was measured as
the shortest distance from the base of a medullary pyra-
mid to the renal capsule (Fig. 1). When possible (and
in most cases), these measurements were made on the
kidney that was biopsied. Echogenicity was quantified
as previously described [8]. Briefly, longitudinal images
of the right kidney, including adjacent liver, were con-
verted into digital files (8-bit, 300 pixels/in) using a Scan-
Maker III scanner (Microtek Lab, Redondo Beach, CA,
USA) with Photoshop 4.0 software (Adobe Systems, San
Jose, CA, USA). Echogenicity was measured as the in-
verse of the ratio of the mean pixel densities of the re-
nal cortex and adjacent liver using ScionImage software
(Scion Corp., Frederick, MD, USA). Because comparison
to liver is required, echogenicity was analyzed only in the
right kidney. Each sonographic parameter was measured
by a single investigator to avoid interobserver variability.
Pathology
Tissue for light microscopic examination was prepared
in the conventional manner. Briefly, needle biopsies were
fixed in formalin, dehydrated in graded alcohols, cleared
in xylene, and infiltrated with paraffin using automated
procedures. Paraffin-embedded tissues were cut at 3 mi-
crons and stained with hematoxlin and eosin (H&E), pe-
riodic acid-Schiff (PAS) reagent, Masson’s trichrome, and
Jones’ methenamine silver stain. Each biopsy contained
at least 13 glomeruli. Biopsies were evaluated in terms
of 4 parameters: (1) glomerular obsolescence, (2) tubular
atrophy, (3) interstitial fibrosis, and (4) interstitial inflam-
mation. Each parameter was measured in every biopsy
using a semiquantitative grading scale ranging from 0
to 5, where a score of 0 signified that 5% or less of the
biopsy was affected; a score of 1, between 6% and 20%; a
score of 2, between 21% and 40%; a score of 3, between
41% and 60%; a score of 4, between 61% and 80%; and
a score of 5, greater than 80%. All cases were scored
by one investigator (E.J.), who was extensively trained
by an experienced nephropathologist (R.A.H.). For qual-
ity assurance, approximately 40% of cases were reviewed
by both investigators, with excellent agreement.
Data analysis
Statistical analysis was performed with SAS version
8.01 software (SAS Institute, Inc., Cary, NC, USA). Uni-
variate analysis is presented as Spearman correlation
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Table 1. Patient data
Interval between
Kidney sonogram and
Age years Gender biopsied biopsy days
45 Male 98 Left 191 16
(15–82) Female 109 Right 16 (−16 −148)
Ranges are given in parentheses.
Table 2. Pathologic diagnosis
Diagnosis Number
Proliferative glomerulonephritis 55
Focal segmental glomerulosclerosis 31
IgA nephropathy 21
Membranous glomerulonephritis 18
Nephrosclerosis 13
Diabetic nephropathy 14
Interstitial disease 9
Thrombotic microangiopathy 10
Amyloidosis 4
Advanced, indeterminant disease 13
Normal 2
Other 11
coefficients. For analysis of sonographic parameters with
each of the 4 histologic parameters, a Bonferonni correc-
tion of 4 was applied to the P value. For comparison of
the incidence of severe disease in different populations,
significance was determined by the chi-square test using
the Yates correction.
RESULTS
Information on the study patients is provided in
Table 1. The mean interval between the diagnostic sono-
gram and the biopsy was 12 days, and 38% of the diagnos-
tic sonograms were performed at the time of the biopsy.
Three diagnostic studies were performed after the biopsy
(8, 11, and 16 days), but not before any therapy had been
instituted. Seven studies were performed more than 2
months before the biopsy. All of these patients had in-
dolent disease that was unlikely to have progressed dur-
ing this interval. It is standard practice at this institution
to biopsy the left kidney, but 8% of the biopsies were
performed on the right kidney because the left kidney
was absent (1 patient), atrophic (2 patients), or contained
cysts (1 patient). In the remaining 11 patients, the reason
for using the right kidney was not specified. The most
common pathologic diagnosis (Table 2) was proliferative
glomerulonephritis, of which 36% were due to systemic
lupus erythematosis (SLE). SLE was also the etiology in
4 of the patients with membranous nephropathy. In 6%,
the renal disease was too advanced to make a specific di-
agnosis. Some patients had more than one diagnosis and
were categorized as having each.
Sonographic data are presented in Table 3. Since renal
length varies with body height and those data were un-
available, it was not possible to determine which kidneys
were outside the normal range. Mean renal length was in
the normal range for subjects aged 40 to 50 years (#180),
but 18% of right kidneys and 15% of left kidneys were less
than 10 cm. The mean difference in length between the 2
kidneys was 7 mm, due principally to a slightly larger left
kidney, which is normal [9]. In only 7 patients (3.4%) was
there a size discrepancy >2 cm, suggestive of asymmetric
disease [10]. Mean echogenicity was increased compared
to our previously established normal range of 0.810 to
0.987, and was above this range in 59% of the patients in
whom it could be measured. This was consistent with the
original qualitative assessment of echogenicity as being
normal (less than the liver) in only 32%. Echogenicity
could not be quantified in 39 studies because the images
were not available or were not suitable for quantitative
analysis. The qualitative assessment of echogenicity in
these studies did not differ from that in the other studies.
Cortical thickness could not be determined in 82 of
the biopsied kidneys (77 left kidneys), primarily because
the medullary pyramids were not sufficiently visible. In
12 of these patients, thickness could be measured in the
other kidney, and this value was used. Based on a nor-
mal range of 8 to 11.5 mm established in a small study of
transplant donors [11], cortical thickness was reduced in
41% and increased in 3% of studies. Parenchymal thick-
ness could be measured on a slightly larger number of
kidneys, but had a wider range, probably because of the
variability within kidneys and the imprecision of its mea-
surement. A normal range has not been established, but
it is probably centered around 15 to 16 mm [12]. There
was no significant correlation between any of the sono-
graphic parameters other than between parenchymal and
cortical thickness.
Composite pathologic data are presented in Table 4.
Each parameter varied through the full range, and there
were 7 biopsies with a zero score on each parameter. Not
surprisingly, all parameters were strongly associated with
each other, with correlation coefficients ranging from 0.41
for glomerulosclerosis and interstitial inflammation to
0.89 for tubular atrophy and interstitial fibrosis. Corre-
lations between sonographic parameters and pathologic
findings are shown in Table 5. Echogenicity correlated
most strongly with tubular atrophy and interstitial inflam-
mation, with slightly weaker correlations with glomeru-
lar sclerosis and interstitial fibrosis. These relationships
are plotted in Figure 2. Of the 62 patients with nor-
mal renal cortical echogenicity (≤0.987), mean scores for
glomerulosclerosis (15 ± 2.2%), interstitial fibrosis (1.4 ±
0.19), and tubular atrophy (1.1 ± 0.14) were sig-
nificantly lower than the scores in patients with in-
creased echogenicity (29 ± 2.4%, 2.6 ± 0.15, and 2.1 ±
0.15). The correlation between pathologic findings and
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Table 3. Sonographic findings
Length cm Cortical echogenicity Cortical thickness Parenchymal thickness
Left Right Diff.a Kidney/liver mm mm
Mean 10.9 10.9 0.7 1.04 8.3 17.1
Median 11.0 11.0 0.6 1.02 8.2 16.3
Range 7.5–15.0 7.6–14.5 0–4.6 0.71–1.89 4.7–12.5 7.0–33.7
N 205 207 205 168 137 145
aDifference in lengths between kidneys.
Table 4. Pathologic findings
Sclerosed Interstitial Tubular Interstitial
glomeruli % fibrosis atrophy inflammation
Mean 24.6 2.3 1.8 1.1
Median 15.0 2 2 1
Range 0–100 0–5 0–5 0–5
Table 5. Spearman correlation coefficients for the relationships
between sonographic parameters and pathologic parameters
Sclerosed Interstitial Tubular Interstitial
glomeruli fibrosis atrophy inflammation
Kidney length −0.26 −.14 −0.20 0.10
P = 0.0002 P = 0.0048 P = 0.0042 P = 0.15
Echogenicity 0.30 0.35 0.28 0.34
P < 0.0001 P < 0.0001 P = 0.0003 P < 0.0001
Parenchymal −0.20 −.19 −0.23 −0.14
thickness P = 0.014 P = 0.025 P = 0.0061 P = 0.097
Cortical −0.15 −0.005 −0.12 0.005
thickness P = 0.08 P = 0.95 P = 0.15 P = 0.95
length was significantly weaker, but was better than for
parenchymal thickness. There was no significant correla-
tion between cortical thickness and any histopathologic
parameter.
Because the histologic parameters were strongly
linked, multivariate analysis was performed to determine
their relative contributions to echogenicity (Table 6). In
this case, interstitial fibrosis was no longer correlated with
echogenicity, and only tubular atrophy and interstitial
inflammation showed significant independent contribu-
tions. The value B indicates the degree to which each
parameter contributed to echogenicity. In the case of
tubular atrophy, each unit increase added 0.051 to the
echogenicity. That tubular atrophy and not interstitial fi-
brosis is an independent determinant of echogenicity is
illustrated by the 2 cases in which the scores for interstitial
fibrosis and tubular atrophy were widely disparate. In a
patient with rapidly progressive glomerulonephritis and
scores for interstitial fibrosis and atrophy of 0 and 4, re-
spectively, echogenicity was 1.021, while in a patient with
chronic thrombotic microangiopathy and scores for in-
terstitial fibrosis and atrophy of 4 and 1, echogenicity was
0.929 (normal). In both cases, the interstitial inflamma-
tion score was 1. The composite r2 for the multivariate
analysis was 0.20, indicating that histologic parameters
accounted for a fifth of the variation in echogenicity.
Two sonographic thresholds (combined kidney length
<20 cm and echogenicity greater than liver) were evalu-
ated to determine their clinical utility (Table 7). For this
purpose, patients with scores of at least 51% for glomeru-
lar sclerosis, 3 for interstitial fibrosis, or 3 for tubular atro-
phy were judged to have severe chronic disease, and 105
cases met this definition. The incidence of severe disease
was approximately 2/3 in small kidneys or in echogenic
kidneys, and was significantly greater than in larger or
nonechogenic kidneys. Combining the thresholds identi-
fied a smaller number of patients, but in whom the inci-
dence of severe chronic disease was very high.
DISCUSSION
This study demonstrates that sonographic determina-
tion of renal length and cortical echogenicity correlates
with chronic, irreversible renal disease. For each histo-
logic measure of disease, the correlation was substan-
tially stronger with echogenicity than with renal length.
Echogenicity was correlated with each histologic param-
eter, but only tubular atrophy and interstitial inflamma-
tion remained significant in a multivariate analysis. Since
it is widely assumed that collagen fibrils contribute impor-
tantly to the acoustic backscatter of tissues [2, 5, 13], it
was surprising that interstitial fibrosis was not an indepen-
dent determinant of echogenicity. It is of interest that a
previous study using qualitative assessment of echogenic-
ity also found no correlation with interstitial fibrosis [4].
Possible mechanisms by which tubular atrophy could in-
crease renal cortical echogenicity include thickening of
the tubular basement membranes or luminal dilatation
of the remaining tubules [14]. We have previously shown
that echogenicity varies directly with diuresis [8], pre-
sumably due to changes in tubular caliber. The patho-
logic parameters accounted for only 20% of the varia-
tion in echogenicity, and it is likely that the remaining
80% is related to variability in the sonographic tech-
nique or image analysis. The possibility that the biopsy
is not representative of the entire kidney may also con-
tribute to the variability. One limitation is that echogenic-
ity could only be determined for the right kidney, whereas
most of the biopsies were obtained from the left kidney.
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Fig. 2. Relationship between renal cortical
echogenicity and pathologic findings.
Table 6. Multivariate analysis with echogenicity as the dependent
variable
Beta Std. error P value
Tubular atrophy 0.051 0.022 <0.001
Interstitial inflammation 0.040 0.015 0.0073
Glomerular sclerosis −0.0016 0.0009 0.0556
Interstitial fibrosis −0.0039 0.021 0.85
However, the disorders present in these patients should
affect both kidneys equally.
Neither parenchymal thickness nor cortical thickness
provided any better correlation with histopathology than
did a simple measurement of renal length. The poor cor-
relations with these direct measures of parenchymal size
can probably be explained by the difficulty in accurately
and reproducibly measuring either thickness. The diag-
nostic studies reported here were not performed with the
intent of accurately determining parenchymal or cortical
thickness so that optimal images for this purpose were of-
ten not obtained. A prior study found a weak correlation
between parenchymal thickness and histology that was
not strong enough to influence the decision to perform a
biopsy [15].
Although kidney length and echogenicity were corre-
lated with histologic findings of chronic disease, neither
parameter alone was a good discriminator. The specificity
for severe chronic disease was only two thirds. Very low
echogenicities excluded very severe glomerular sclero-
sis, interstitial fibrosis, or tubular atrophy, but elevated
echogenicities were not useful. The lack of discrimina-
tion by increased echogenicity may be related to inter-
stitial inflammation, which was an important cause of
increased echogenicity, but is potentially reversible and
not necessarily an indication of chronic disease. Combin-
ing kidney length and echogenicity provided much better
discrimination, with 86% of patients having combined
kidney length <20 cm and echogenicity >1.0 (greater
than the liver), demonstrating severe chronic disease in
the biopsy. Although these conclusions are hampered
by the small numbers, it is likely that specificity is even
greater in the overall population of renal disease. There
were undoubtedly a large number of patients with small
echogenic kidneys and severe disease in whom biopsy was
not performed, whereas almost all patients with normal-
appearing kidneys are likely to have undergone biopsy.
CONCLUSION
This study is the first systematic comparison of sono-
graphic findings with renal histopathology. It shows that
renal cortical echogenicity is determined primarily by
tubular atrophy and interstitial inflammation, and is the
sonographic parameter that correlates best with patho-
logic findings. While reduced renal length or increased
echogenicity alone lack specificity for severe chronic dis-
ease, together they demonstrated good specificity, sup-
porting the current clinical practice. Measurement of
parenchymal or cortical thickness was not useful.
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Table 7. Histopathology at different thresholds for sonographic parameters
% Severe % Sclerosed Interstitial
Parameter N disease glomeruli fibrosis Tubular atrophy
Combined length <20 cm 32 69a 36 ± 4 3.1 ± 0.3 2.3 ± 0.3
Combined length ≥20 cm 175 47 23 ± 2 2.1 ± 0.1 1.7 ± 0.1
Echogenicity >1.0 99 66b 30 ± 3 2.7 ± 0.2 2.1 ± 0.2
Echogenicity ≤1.0 69 30 14 ± 2 1.6 ± 0.2 1.2 ± 0.1
Combined length <20 cm and echogenicity >1.0 21 86b 46 ± 5 3.5 ± 0.2 2.7 ± 0.3
Combined length ≥20 cm or echogenicity ≤1.0 147 46 20 ± 2 2.1 ± 0.1 1.6 ± 0.1
Errors are standard errors.
aP < 0.05.
bP < 0.001.
Reprint requests to W. Charles O’Neill, M.D., Emory University
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